At a glance
ClinicalIndex Comparison RecordN/ACompleted· 84 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Validation of a Level 2 Sleep Study Device
In Brief
An observational study for Sleep Apnea. Completed, enrolled 84 participants across 2 sites in 2 countries.
Detailed Summary
The Prodigy system, developed by Cerebra Medical Ltd, allows for the generation of the same information in the home that is currently only obtained in in-laboratory studies. The objective of the current study is to demonstrate that the signals obtained by this comprehensive, portable system are comparable to those obtained in in-laboratory studies.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSleep Apnea
CountriesCanada, United States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
First PostedNov 2021
Enrollment StartJan 2022
Primary CompletionApr 2022
TodayJul 2026
First PostedNov 10, 2021
Enrollment StartJan 14, 2022
Primary CompletionApr 9, 2022
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 4.6 years ago